These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 16898511)

  • 21. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Calcium to Citrate Ratio in Predicting Stone Formation in Idiopathic Hypercalciuria Children (2-12 Years Old).
    Kompani F; Valavi E; Amuri P; Mohtasham N
    J Ren Nutr; 2019 Mar; 29(2):97-101. PubMed ID: 30322785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
    DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
    Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M; Anders D; Graef V; Bödeker RH
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and metabolic abnormalities in preschool-age children with urolithiasis in southeast Anatolia.
    Elmacı AM; Ece A; Akın F
    J Pediatr Urol; 2014 Jun; 10(3):495-9. PubMed ID: 24314604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric urolithiasis--evaluation of risk factors in 95 children.
    Erbagci A; Erbagci AB; Yilmaz M; Yagci F; Tarakcioglu M; Yurtseven C; Koyluoglu O; Sarica K
    Scand J Urol Nephrol; 2003; 37(2):129-33. PubMed ID: 12745721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of urine alkalization on excretion of renal citrate and degree of urine saturation with calcium oxalate in patients with calcium-oxalate urolithiasis and in healthy subjects].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Feb; 91(2):77-83. PubMed ID: 8008619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary calcium and uric acid excretion in children with vesicoureteral reflux.
    Madani A; Kermani N; Ataei N; Esfahani ST; Hajizadeh N; Khazaeipour Z; Rafiei S
    Pediatr Nephrol; 2012 Jan; 27(1):95-9. PubMed ID: 21814729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasting urinary calcium-to-creatinine and oxalate-to-creatinine ratios in dogs with calcium oxalate urolithiasis and breed-matched controls.
    Furrow E; Patterson EE; Armstrong PJ; Osborne CA; Lulich JP
    J Vet Intern Med; 2015 Jan; 29(1):113-9. PubMed ID: 25581880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypocitraturia in patients with urolithiasis.
    Akçay T; Konukoğlu D; Celik C
    Arch Dis Child; 1996 Apr; 74(4):350-1. PubMed ID: 8669940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers.
    Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Leavitt DA; Moeding A; Stessman M; Monga M
    Urology; 2012 Feb; 79(2):282-6. PubMed ID: 22000931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies of citrate metabolism in urolithiasis. 2--Influences of citrate compound administration on sequential excretion of urinary citrate and other substances related to stone formation in healthy controls].
    Yasukawa S; Uehara M; Morimoto S; Yoshida T; Fukatani T; Ebisuno S; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1987 Apr; 78(4):626-33. PubMed ID: 3669471
    [No Abstract]   [Full Text] [Related]  

  • 36. Pediatric urolithiasis in a non-endemic country: a single center experience from The Netherlands.
    Rellum DM; Feitz WF; van Herwaarden AE; Schreuder MF
    J Pediatr Urol; 2014 Feb; 10(1):155-61. PubMed ID: 23981680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal colonization with Oxalobacter formigenes and its relation to urinary oxalate excretion in pediatric patients with idiopathic calcium urolithiasis.
    Sikora P; Niedźwiadek J; Mazur E; Paluch-Oleś J; Zajaczkowska M; Kozioł-Montewka M
    Arch Med Res; 2009 Jul; 40(5):369-73. PubMed ID: 19766900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ; Jeon SS; Han DH; Lee SY
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.